An International Collaboration to Harmonize the Quantitative Plasma Epstein-Barr Virus (EBV) DNA Assay for Future Biomarker-Guided Trials in Nasopharyngeal Carcinoma

PURPOSE: Persistently elevated post-treatment plasma EBV DNA is a robust predictor of relapse in NPC. However, assay standardization is necessary for use in biomarker-driven trials. We conducted a study to harmonize the method between four centers with expertise in EBV DNA quantitation. EXPERIMENTAL...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Le, Quynh-Thu, Zhang, Qiang, Cao, Hongbin, Cheng, Ann-Joy, Pinsky, Benjamin A., Hong, Ruey-Long, Chang, Joseph T, Wang, Chun-Wei, Tsao, Kuo-Chien, Lo, YM Dennis, Lee, Nancy, Ang, K. Kian, Chan, Anthony TC, Chan, KC Allen
Médium: Artigo
Jazyk:Inglês
Vydáno: 2013
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3630245/
https://ncbi.nlm.nih.gov/pubmed/23459720
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-12-3702
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky